Joseph Michael Fitzgerald - 12 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Feb 2024
Net transactions value
$0
Form type
4
Filing time
14 Feb 2024, 16:21:59 UTC
Previous filing
08 Feb 2024
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Gift $0 -6,000 -3.2% $0.000000 184,354 12 Feb 2024 Direct
transaction BSX Common Stock Gift $0 +550 +13% $0.000000 4,894 12 Feb 2024 By Child F1
holding BSX Common Stock 67,974 12 Feb 2024 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +13,848 $0.000000 13,848 12 Feb 2024 Common Stock 13,848 Direct F3, F4
transaction BSX Stock Option (Right to Buy) Award $0 +36,509 $0.000000 36,509 12 Feb 2024 Common Stock 36,509 $64.99 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.